April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
A Novel 3D Scar Model for Assessing the Effect of TGF-β Isoforms in Corneal Fibroblasts
Author Affiliations & Notes
  • D. Karamichos
    Schepens Eye Research Institute, Boston, Massachusetts
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • A. E. K. Hutcheon
    Schepens Eye Research Institute, Boston, Massachusetts
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • X. Q. Guo
    Schepens Eye Research Institute, Boston, Massachusetts
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • J. D. Zieske
    Schepens Eye Research Institute, Boston, Massachusetts
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  D. Karamichos, None; A.E.K. Hutcheon, None; X.Q. Guo, None; J.D. Zieske, None.
  • Footnotes
    Support  NIH Grant R21EY018939
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4538. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. Karamichos, A. E. K. Hutcheon, X. Q. Guo, J. D. Zieske; A Novel 3D Scar Model for Assessing the Effect of TGF-β Isoforms in Corneal Fibroblasts. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4538.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : One of the most devastating outcomes of a corneal wound is the onset of corneal fibrosis leading to a scar. Corneal fibrosis is characterized by the presence of myofibroblasts and improper deposition of extracellular matrix components (ECM). TGF-β1 (T1) is known to stimulate overproduction and deposition of ECM components; however, two more isoforms are present: TGF-β2 and -β3 (T2 and T3). We have developed an in-vitro 3D scar model using human corneal fibroblasts (HCF) in order to investigate the effect of these three isoforms.

Methods: : HCF were stimulated by a stable Vitamin C (VitC) derivative ± 0.1ng/ml of either T1, T2, or T3. HCF were grown for 4 and 8 weeks and analyzed by indirect-immunofluorescence microscopy.

Results: : All three TGF-β isoforms stimulated matrix production by ~3 times compared to controls. High levels of collagen III with T1, T2 and T3 were seen; however, the timing and the localization varied: While T1 did not show expression of collagen III until week 8, T3 lost the expression by that time. T2 showed expression in the top-most layers at both time points. Alpha-smooth muscle-actin (SMA) expression was seen in all constructs, with the number of myofibroblasts being far greater in T1 and T2. At week 4, Thrombospondin-1 (TSP-1) was found in the middle of the constructs; in the top layers for T3, in the bottom layers for T2, and was absent in T1. By week 8, the control and T3 samples showed similar expression to week 4; however, T1 showed an increase. Finally, fibronectin (cFN) was absent from the controls at week 4; however, intense cFN expression appeared in T1 and T2 in the top layers; whereas, cFN expression was present almost throughout the T3 construct. At week 8, none of the constructs expressed cFN.

Conclusions: : All three isoforms stimulate matrix deposition in this 3D model; however, differences in the timing, as well as, the localization of specific proteins associated with scarring, such as collagen III and cFN were observed. The development of a human corneal scar model will allow for the examination of the regulation of corneal scar matrix formation, secretion, and organization.

Keywords: cornea: stroma and keratocytes • growth factors/growth factor receptors • extracellular matrix 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×